Herpes Cure Research in 2027: Vaccines, Gene Editing and New Drugs
HSV-1 and HSV-2 together infect more than 4 billion people. WHO estimates that about 3.8 billion people under 50 carry HSV-1 and roughly 520 million people...
Read Morenews
11 articles tagged with this topic
New Hope for Herpes: Scientists Turn to Animals' Immune Secrets
For decades, treating herpes has meant accepting a stalemate. Drugs like acyclovir do their job (they stop the virus from replicating inside infected cells)...
Read More
Herpes Viruses Against Cancer: FDA Approves a Second HSV-Based Melanoma Drug
Herpes simplex virus is best known for cold sores and genital herpes, but modified versions of it are now approved cancer drugs. On August 6, 2026, the FDA...
Read More
Herpes Cure Research in 2026: Vaccines, Gene Editing and New Drugs
Editorial note: This page is no longer updated. For the latest on pritelivir's FDA review, Gilead's weekly pill and gene editing trials, see our herpes cure...
Read MoreHerpes Vaccine Outlook From May 2025: Why 2026 Was Always Unlikely
Editorial note: This article was written in May 2025 and reflects the herpes vaccine landscape as it stood at that time. Since then, Moderna has stopped its...
Read More
Penn Dental Medicine Develops Antiviral Gum with Lablab Bean Protein to Reduce Flu and Herpes Transmission
May 24, 2025 - Researchers at the University of Pennsylvania’s School of Dental Medicine have unveiled an innovative antiviral chewing gum that significantly...
Read More
Herpes and Alzheimer's: What the Research Shows After the VALAD Trial
Herpes simplex virus type 1 (HSV-1), the virus behind most cold sores, has been linked to Alzheimer's disease for more than 30 years. Large health-record...
Read More
Will There Be A Cure For Herpes in 2025?
Editorial note: This article covers herpes cure research as it stood in 2025. For the current picture, including Moderna's exit from herpes vaccines and the...
Read More
GSK Discontinues HSV Vaccine After Failed Phase I/II Trial
In September 2024, GlaxoSmithKline (GSK) announced it was discontinuing its investigational herpes simplex virus vaccine candidate, GSK3943104, after it failed...
Read More
Gene Editing Therapy Clears Most Latent Herpes in Mice
In a remarkable development that could change the lives of millions affected by herpes, researchers at the Fred Hutchinson Cancer Center have made a...
Read More
WSU Secures $1.2 Million Grant for Groundbreaking HSV Research
January 2024 - A research team at Washington State University (WSU) received a four-year, $1.2 million grant from the National Institutes of Health to study...
Read More